Compare TORM plc (TRMD) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
TORM plc vs Zimmer Biomet Holdings Inc — how do they compare? TORM plc trades at $29.89 (market cap $2.99B), while Zimmer Biomet Holdings Inc trades at $90.03 (market cap $17.36B). The key difference: Zimmer Biomet Holdings Inc is far larger — about 5.8× TORM plc's market cap, and TORM plc pays the higher dividend (9.62%). Which is the better fit depends on your goals.
| TRMD | ZBH | |
|---|---|---|
Market Cap | $2.99B | $17.36B |
Sector | Technology | Health |
52-Week High | $34.87 | $107.71 |
52-Week Low | $17.50 | $79.58 |
Enterprise Value | $3.88B | $24.40B |
Dividend Yield | 9.62% | 1.07% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TRMD trades at $29.08, up 2.21% today, with a bullish technical signal from moving averages. The company reported strong 2025 results with $1.34B revenue and $285.3M net income, though recent Q1 2026 EPS missed expectations. Valuation ratios appear attractive with a P/E of 8.54 and P/S of 2.08. Recent news highlights strong cash generation and a potential merger with Hafnia.
The outlook is positive with 100% analyst buy ratings and a near 9% dividend yield. Key risks include earnings volatility and market exposure, but disciplined capital allocation and high profitability margins support upside potential.
Zimmer Biomet (ZBH) trades at $88.92, down 2.41% on the day, with a bearish technical signal but strong fundamentals including a 70.03% gross margin and three consecutive quarterly EPS beats. Revenue grew to $8.23B in 2025, though net income margin compressed to 8.56%. The company announced a $1 billion share repurchase increase and expansion in India, while maintaining a dividend.
The stock offers a 10% upside to the $97.67 consensus price target, supported by value metrics and operational strength, but faces risks from rising debt levels and competitive pressures. Analyst sentiment is mixed with 40% buy ratings, suggesting cautious optimism amid near-term technical weakness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About TORM plc
TORM plc is one of the world's largest owners and operators of product tankers, specializing in the transportation of refined oil products like gasoline, jet fuel, and diesel. Operating under its integrated 'One TORM' model, the company maintains a modern, wholly-owned fleet of nearly 90 vessels. It is widely recognized by investors for its aggressive variable dividend policy, which returns a significant portion of its cash flow directly to shareholders during periods of high freight rates.
Read more on TRMD →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
